Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$2.31 - $5.13 $111,804 - $248,292
-48,400 Reduced 80.27%
11,900 $28,000
Q4 2021

Feb 15, 2022

SELL
$4.45 - $8.09 $47,170 - $85,754
-10,600 Reduced 14.95%
60,300 $287,000
Q3 2021

Nov 16, 2021

SELL
$6.94 - $8.85 $1.26 Million - $1.61 Million
-181,800 Reduced 71.94%
70,900 $555,000
Q2 2021

Aug 16, 2021

BUY
$7.45 - $16.27 $1 Million - $2.19 Million
134,700 Added 114.15%
252,700 $2.04 Million
Q1 2021

May 18, 2021

BUY
$8.78 - $12.8 $611,088 - $890,880
69,600 Added 143.8%
118,000 $1.34 Million
Q4 2020

Feb 17, 2021

BUY
$1.08 - $8.2 $52,272 - $396,879
48,400 New
48,400 $396,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.